Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
AST.WS was delisted on the 26th of September, 2017.
3 hedge funds and large institutions have $0 invested in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 30 closing their positions.
91% less funds holding
Funds holding: 33 → 3 (-30)
97% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 30
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $449K → $0 (-$449K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadwood Capital
New York
|
-$164K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$84K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$65K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$45K |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Broadwood Capital
New York
| – | -$164K | -328,205 | Closed |
|
|
2
Fidelity Investments
Boston,
Massachusetts
| – | -$84K | -168,703 | Closed |
|
|
CL
3
CSS LLC
Chicago,
Illinois
| – | -$65K | -129,837 | Closed |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| – | -$45K | -89,777 | Closed |
|
|
MHP
5
Manatuck Hill Partners
Westport,
Connecticut
| – | -$38K | -75,000 | Closed |
|
|
BCM
6
Bridgeway Capital Management
Houston,
Texas
| – | -$15K | -29,609 | Closed |
|
7
Goldman Sachs
New York
| – | -$10K | -20,530 | Closed |
|
8
Northern Trust
Chicago,
Illinois
| – | -$9K | -17,548 | Closed |
|
9
UBS Group
Zurich,
Switzerland
| – | -$2K | -3,870 | Closed |
|
10
BlackRock
New York
| – | -$1K | -2,856 | Closed |
|
11
New York State Common Retirement Fund
Albany,
New York
| – | -$1K | -1,920 | Closed |
|
12
Morgan Stanley
New York
| – | -$1K | -1,345 | Closed |
|
|
AIG
13
American International Group
New York
| – | -$1K | -1,222 | Closed |
|
14
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1K | -1,008 | Closed |
|
|
NSIM
15
North Star Investment Management
Chicago,
Illinois
| – | +$5 | +16 | New |
|
AST.WS Hedge Fund Activity: Q3 2017 in Review
3 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) for Q3 2017, worth a combined $0 — down 100% from $449K a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of AST.WS and 1 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was North Star Investment Management, opening a new position worth an estimated $5. The largest seller was Broadwood Capital, exiting entirely with an estimated $164K sold.
- 3 institutional investors held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) as of Q3 2017, down from 33 in Q2 2017.
- Funds reported $0 of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) stock for Q3 2017, down 100% quarter-over-quarter.
- 1 fund opened new Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) positions in Q3 2017 and 30 closed out, a net change of -29 holders.
- The largest Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) buyer in Q3 2017 was North Star Investment Management, an estimated $5 added.
- The largest Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) seller in Q3 2017 was Broadwood Capital, an estimated $164K sold.
Based on aggregated 13F filings for Q3 2017.